Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Davidson

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Pediatric Blood & Cancer|October 23, 2023
Extracranial germ cell tumours: Mature and immature (1990-2015). First report by the South African Association of Paediatric Haematology Oncology (SAAPHO)Marc Hendricks, Annibale Cois, Jennifer Geel, et al.
Journal of Translational Medicine|September 16, 2020
Prognostic factors in patients admitted to an urban teaching hospital with COVID-19 infectionDonogh Maguire, Marylynne Woods, Conor Richards, et al.
The Lancet. Oncology|July 6, 2023
Addressing the childhood cancer crisis in sub-Saharan AfricaJoseph Lubega, Lulu Chirande, Barnabas Atwine, et al.
Pediatric Blood & Cancer|August 14, 2020
SIOP PODC-adapted treatment guidelines for craniopharyngioma in low- and middle-income settingsNisreen Amayiri, Ariane Spitaels, Mohamed Zaghloul, et al.
Plos One|May 27, 2021
The systemic inflammatory response and clinicopathological characteristics in patients admitted to hospital with COVID-19 infection: Comparison of 2 consecutive cohortsDonogh Maguire, Conor Richards, Marylynne Woods, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 2016
Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia, Eliane Rohner, Kurt Schmidlin, et al.
Rheumatology (Oxford, England)|February 3, 2026
The development of a risk threshold to aid risk stratified approach to monitoring for haematological, hepatic and/or renal adverse drug reactions during established conventional synthetic DMARD treatment for systemic autoimmune rheumatic diseases: a RAND/UCLA Appropriateness Method consensus studyJoanne Ablewhite, Georgina Nakafero, Abdullah Almayahi, et al.
Rheumatology Advances in Practice|July 15, 2024
The prescription and monitoring of conventional synthetic disease-modifying anti-rheumatic drugs: British Society for Rheumatology guideline scopeLouise Mercer, Abhishek Abhishek, Akhila Kavirayani, et al.
BMJ Global Health|July 25, 2025
Paediatric haematology/oncology workforce and training programmes for Africa: a regional analysisDiriba Fufa, Asmaa Attia, Nihad Salifu, et al.
Rheumatology (Oxford, England)|November 14, 2025
The 2025 British Society for Rheumatology guideline for the prescription and monitoring of conventional synthetic disease-modifying anti-rheumatic drugsKatie Bechman, Kaiyang Song, Abhishek Abhishek, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Pediatric Blood & Cancer|October 23, 2023
Extracranial germ cell tumours: Mature and immature (1990-2015). First report by the South African Association of Paediatric Haematology Oncology (SAAPHO)Marc Hendricks, Annibale Cois, Jennifer Geel, et al.
Journal of Translational Medicine|September 16, 2020
Prognostic factors in patients admitted to an urban teaching hospital with COVID-19 infectionDonogh Maguire, Marylynne Woods, Conor Richards, et al.
The Lancet. Oncology|July 6, 2023
Addressing the childhood cancer crisis in sub-Saharan AfricaJoseph Lubega, Lulu Chirande, Barnabas Atwine, et al.
Pediatric Blood & Cancer|August 14, 2020
SIOP PODC-adapted treatment guidelines for craniopharyngioma in low- and middle-income settingsNisreen Amayiri, Ariane Spitaels, Mohamed Zaghloul, et al.
Plos One|May 27, 2021
The systemic inflammatory response and clinicopathological characteristics in patients admitted to hospital with COVID-19 infection: Comparison of 2 consecutive cohortsDonogh Maguire, Conor Richards, Marylynne Woods, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 2016
Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia, Eliane Rohner, Kurt Schmidlin, et al.
Rheumatology (Oxford, England)|February 3, 2026
The development of a risk threshold to aid risk stratified approach to monitoring for haematological, hepatic and/or renal adverse drug reactions during established conventional synthetic DMARD treatment for systemic autoimmune rheumatic diseases: a RAND/UCLA Appropriateness Method consensus studyJoanne Ablewhite, Georgina Nakafero, Abdullah Almayahi, et al.
Rheumatology Advances in Practice|July 15, 2024
The prescription and monitoring of conventional synthetic disease-modifying anti-rheumatic drugs: British Society for Rheumatology guideline scopeLouise Mercer, Abhishek Abhishek, Akhila Kavirayani, et al.
BMJ Global Health|July 25, 2025
Paediatric haematology/oncology workforce and training programmes for Africa: a regional analysisDiriba Fufa, Asmaa Attia, Nihad Salifu, et al.
Rheumatology (Oxford, England)|November 14, 2025
The 2025 British Society for Rheumatology guideline for the prescription and monitoring of conventional synthetic disease-modifying anti-rheumatic drugsKatie Bechman, Kaiyang Song, Abhishek Abhishek, et al.
Pageof 11